Two University of Cambridge neuroscientists writing in The Lancet Psychiatry are calling for “immediate action” by governments, the pharmaceutical industry, and medical organizations to better understand the risks of people increasingly using drugs like Ritalin and Provigil to “enhance” their cognitive functions.
Sahakian, Barbara J, and Sharon Morein-Zamir. “Pharmacological Cognitive Enhancement: Treatment of Neuropsychiatric Disorders and Lifestyle Use by Healthy People.” The Lancet Psychiatry 2, no. 4 (n.d.): 357–62. Accessed April 10, 2015. doi:10.1016/S2215-0366(15)00004-8. (Full text with free registration)